OptiNose, Inc. announced preliminary XHANCE net product revenue results for the first quarter ended March 31, 2024. for the quarter, the company reported preliminary XHANCE net product revenue of $14.9 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.03 USD | -9.65% | +25.46% | -20.16% |
Apr. 25 | OptiNose, Inc. Provides Revenue Guidance for the First Quarter of 2024 | CI |
Apr. 25 | Transcript : OptiNose, Inc. - Special Call |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.16% | 116M | |
+33.43% | 700B | |
+26.43% | 569B | |
-5.12% | 358B | |
+19.59% | 330B | |
+4.89% | 287B | |
+14.32% | 236B | |
+5.79% | 202B | |
-9.49% | 197B | |
+4.26% | 161B |
- Stock Market
- Equities
- OPTN Stock
- News OptiNose, Inc.
- Optinose, Inc. Announces Preliminary XHANCE Net Product Revenue Results for the First Quarter Ended March 31, 2024